Janus Henderson Group’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-4,476,193
Closed -$83.5M – 2746
2022
Q1
$83.5M Sell
4,476,193
-3,592,340
-45% -$64.6M 0.04% 361
2021
Q4
$173M Sell
8,068,533
-169,553
-2% -$3.34M 0.07% 261
2021
Q3
$152M Buy
8,238,086
+1,873,161
+29% +$37.7M 0.07% 281
2021
Q2
$136M Sell
6,364,925
-721,162
-10% -$14.7M 0.06% 309
2021
Q1
$137M Buy
+7,086,087
New +$125M 0.06% 300

Other funds holding OCDX

Janus Henderson Group's OCDX Position: Q2 2022 in Review

Janus Henderson Group sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q2 2022, closing a stake of 4,476,193 shares — an estimated $83.5M sold.

Janus Henderson Group first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $173M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Janus Henderson Group reported no remaining Ortho Clinical Diagnostics Holdings position as of Q2 2022 after selling out during the quarter.
  • Janus Henderson Group sold 4,476,193 Ortho Clinical Diagnostics Holdings shares in Q2 2022, an estimated $83.5M.
  • Janus Henderson Group first reported a position in Ortho Clinical Diagnostics Holdings in Q1 2021 and held it in 5 quarters.
  • Janus Henderson Group's Ortho Clinical Diagnostics Holdings position peaked at $173M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q2 2022.

Based on Janus Henderson Group's 13F filing for Q2 2022, filed 15 Aug 2022.